Hill-Rom Holdings Inc. (NYSE:HRC) shares saw unusually-strong trading volume on Friday . Approximately 745,377 shares changed hands during mid-day trading, an increase of 29% from the previous session’s volume of 575,847 shares.The stock last traded at $59.04 and had previously closed at $58.44.

Several research analysts have weighed in on HRC shares. Morgan Stanley raised Hill-Rom Holdings from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $54.00 to $62.00 in a research report on Thursday, June 16th. KeyCorp reaffirmed a “buy” rating and issued a $59.00 target price on shares of Hill-Rom Holdings in a research report on Thursday, June 23rd. Zacks Investment Research raised Hill-Rom Holdings from a “hold” rating to a “buy” rating and set a $64.00 target price on the stock in a research report on Tuesday, August 9th. Finally, Bank of America Corp. reaffirmed a “buy” rating and issued a $69.00 target price on shares of Hill-Rom Holdings in a research report on Monday, May 2nd. One analyst has rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $61.50.

The company has a market cap of $3.88 billion and a price-to-earnings ratio of 61.03. The company’s 50-day moving average price is $54.41 and its 200 day moving average price is $50.48.

Hill-Rom Holdings (NYSE:HRC) last announced its quarterly earnings data on Thursday, August 4th. The medical technology company reported $0.81 EPS for the quarter, topping analysts’ consensus estimates of $0.76 by $0.05. The company had revenue of $655.40 million for the quarter, compared to analyst estimates of $647.75 million. The firm’s revenue for the quarter was up 38.1% on a year-over-year basis. During the same period last year, the firm earned $0.62 earnings per share. On average, equities research analysts expect that Hill-Rom Holdings Inc. will post $3.33 earnings per share for the current year.

A hedge fund recently bought a new stake in Hill-Rom Holdings stock. Marshall Wace LLP bought a new stake in Hill-Rom Holdings Inc. (NYSE:HRC) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 34,840 shares of the medical technology company’s stock, valued at approximately $1,674,000. Marshall Wace LLP owned about 0.05% of Hill-Rom Holdings at the end of the most recent quarter.

Hill-Rom Holdings, Inc is a medical technology company. The Company offers patient care solutions that improve clinical and economic outcomes in advancing mobility, wound care and prevention, clinical workflow, surgical safety and efficiency, and respiratory health areas. Its segments include North America, Surgical and Respiratory Care, International and Welch Allyn.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.